Nicolas Koutlidis
University of Burgundy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicolas Koutlidis.
The Journal of Urology | 2010
Anne Delgal; Jean-Pierre Cercueil; Nicolas Koutlidis; Frédéric Michel; Isabelle Kermarrec; Eric Mourey; Luc Cormier; D. Krausé; Romaric Loffroy
PURPOSE We evaluated the efficacy and outcomes of transcatheter arterial embolization for intractable bladder or prostate bleeding after failed conservative treatment. MATERIALS AND METHODS We retrospectively studied the records of 2 women and 18 men with a mean +/- SD age of 73 +/- 17.2 years referred between 1999 and 2008 for selective pelvic angiography after failed conventional therapy. Embolization was feasible in 18 patients, including bilateral and unilateral embolization in 13 and 5, respectively. It consisted of superselective distal particulate or glue embolization of the vesical or prostatic arteries in 11 patients, selective proximal coil or gelatin sponge particle occlusion of the anterior division of the internal iliac artery in 2, the 2 techniques in 3 and coil blockade in 2. Clinical bleeding control and post-embolization angiography findings were used to assess outcomes. RESULTS The technical success rate was 90% (18 of 20 cases). Bleeding was controlled after the first procedure in 15 of 18 patients (83.3%) and after a repeat procedure in the remaining 3. The periprocedural mortality rate was 20% (4 of 20 patients) and all deaths were related to underlying conditions. No major complications related to catheterization occurred. Late bleeding recurrence was reported in 4 of the 14 survivors (28.6%). Mean post-embolization followup was 16 months (range 15 days to 56 months). During followup 6 more patients died, including 2 of repeat bleeding. CONCLUSIONS Selective angiographic embolization is safe and effective to control refractory, life threatening bladder or prostate bleeding. This procedure should be considered the treatment of choice since it usually obviates the need for emergency surgery in these severely ill patients.
International Journal of Urology | 2012
Nicolas Koutlidis; Eric Mourey; Jacqueline Champigneulle; Philippe Mangin; Luc Cormier
Objectives: To compare positive surgical margin rates after robot‐assisted and pure laparoscopic radical prostatectomy when neurovascular bundles are preserved, and to identify parameters affecting surgical margin status.
Urologic Oncology-seminars and Original Investigations | 2017
Pierre Bigot; Jean-Christophe Bernhard; Vincent Flamand; Inderbir S. Gill; G. Verhoest; Jean Baptiste Beauval; François Xavier Nouhaud; Evren Süer; G. Ploussard; Jean François Hetet; J. Rigaud; Eduard Baco; S. Larré; Philippe Sebe; Nicolas Koutlidis; Aurélien Descazeaud; Masatoshi Eto; Arnaud Doerfler; Morgan Rouprêt; Nam Son Vuong; B. Reix; Toru Matsugasumi; Adnan El Bakri; Laurence Albiges; Michel Soulie; Jean-Jacques Patard; Arnaud Mejean; Karim Bensalah
OBJECTIVE To evaluate the oncologic outcomes of nephron-sparing surgery (NSS) for localized chromophobe renal cell carcinoma (cRCC). MATERIAL AND METHODS We performed a multicenter international study involving the French Network for Research on Kidney Cancer (UroCCR) and 5 international teams. Data from 808 patients treated with NSS between 2004 and 2014 for non-clear cell RCCs were analyzed. RESULTS We included 234 patients with cRCC. There were 123 (52.6%) females. Median age was 61 (23-88) years. Median tumor size was 3 (1-11)cm. A positive surgical margin was identified in 14 specimens (6%). Pathologic stages were T1, T2, and T3a in 202 (86.3%), 9 (3.8%), and 23 (9.8%) cases, respectively. After a mean follow-up of 46.6 ± 36 months, 2 (0.8%) patients experienced a local recurrence. No patient had metastatic progression, and no patient died from cancer. Three-years estimated cancer-free survival and cancer-specific survival were 99.1% and 100%, respectively. CONCLUSION Oncological results of NSS for localized cRCC are excellent. In this series, only 2 patients had a local recurrence, and no patient had metastatic progression or died from cancer.
Progres En Urologie | 2010
Pierre Bigot; B. Campillo; M. Orsat; Jean-Christophe Bernhard; Romain Mathieu; Nicolas Koutlidis; Souhil Lebdai; Evanguelos Xylinas; S. Beley; Isabelle Richard; Jean-Paul Saint-André; Abdel Rahmene Azzouzi; Morgan Rouprêt
OBJECTIVES Our purpose was to determine how the medical students from the second cycle perceived urology and what their learning methods were. MATERIAL AND METHODS An e-questionnaire was sent to 1600 students in 16 teaching faculties during the last year of their second cycle. RESULTS Overall, we obtained 590 answers (36.8%). In our population, 70.2% of the students were women. Of them, 24.1% had been already enrolled in an academic urology unit. Urology was defined as a medical, surgical and medico-surgical discipline by 3.7%, 37.8% and 58% of the students, respectively. Urology was considered as very important, important, not very important and not important at all by 5.1%, 54.4%, 37.5% and 2.4% of the students. The teaching methods used to learn urology were duplicated-notes for ENC preparation (45.3%), conferences for ENC (French national ranking exam) preparation (43.7%), courses of the national urology college (38.6%) and courses of the faculty (32%). The best mastered items were lithiasis disease (86.3%), voiding dysfunction (76.3%) and urological cancers (56.7%). On the contrary, only 34.7% and 28% considered their knowledge sufficient on the erectile dysfunctions and on renal transplantation. Lastly, 7.3% intended to become urologists. Having a work experience in a urology unit was significantly associated to the feeling of being prepared to become an intern (p<0.001) and to the project of becoming a urologist (p<0.001). CONCLUSION Urology was considered like an important discipline by half of the students at the end of the second cycle even though it is under-represented in the national teaching programme for ENC. A third of the students used courses from the faculty to learn urology and a quarter of them had a work experience in a urology unit during their second cycle.
European Urology | 2016
J.-N. Cornu; Geraldine Cancel-Tassin; David G. Cox; Morgan Rouprêt; Nicolas Koutlidis; Pierre Bigot; Antoine Valeri; V. Ondet; Cecile Gaffory; Georges Fournier; A.R. Azzouzi; Luc Cormier; Olivier Cussenot
UNLABELLED Prostate-specific antigen (PSA) is still the cornerstone of prostate cancer (PCa) screening and diagnosis in both research and current clinical practice. Inaccuracy of PSA is partly due to the influence of a number of genetic, clinical, and biological factors modifying PSA blood levels. In the present study, we detailed the respective influence of each factor among age, body mass index (BMI), prostate volume, and five single-nucleotide polymorphisms-rs10788160 (10q26), rs10993994 (10q11), rs11067228 (12q24), rs17632542 (19q13.33), and rs2928679 (8p21)-on PSA values in a cohort of 1374 men without PCa. Our results show that genetic factors, when risk variants are combined, influence PSA levels with an effect size similar to that of BMI. Taken together, the respective correlations of clinical parameters and genetic parameters would make it possible to correct and adjust PSA values more effectively in each individual. These results establish the basis to understand and implement a more personalised approach for the interpretation of PSA blood levels in the context of PCa screening and diagnosis. PATIENT SUMMARY Prostate-specific antigen (PSA) values in an individual may vary according to genetic predisposition. The effect size of this variation can be significant, comparable with those resulting from clinical characteristics. Personalised PSA testing should take this into account.
Progres En Urologie | 2018
B. Reix; Jean Christophe Bernhard; Jean Jacques Patard; Pierre Bigot; A Villers; Evren Süer; Nam Son Vuong; G. Verhoest; Q. Alimi; Jean Baptiste Beauval; T. Benoit; François Xavier Nouhaud; C. Lenormand; N Hamidi; J Cai; Masatoshi Eto; Stéphane Larré; A El Bakhri; Guillaume Ploussard; A Hung; Nicolas Koutlidis; A. Schneider; J Carrouget; S. Droupy; S Marchal; Arnaud Doerfler; S Seddik; Toru Matsugasumi; X Orsoni; A Descazeaud
BACKGROUND Partial nephrectomy (PN) is recommended as first-line treatment for cT1 stage kidney tumors because of a better renal function and probably a better overall survival than radical nephrectomy (RN). For larger tumors, PN has a controversial position due to lack of evidence showing good cancer control. The aim of this study was to compare the results of PN and RN in cT2a stage on overall survival and oncological results. METHOD A retrospective international multicenter study was conducted in the frame of the French kidney cancer research network (UroCCR). We considered all patients aged≥18 years who underwent surgical treatment for localized renal cell carcinoma (RCC) stage cT2a (7.1-10cm) between 2000 and 2014. Cox and Fine-Gray models were performed to analyze overall survival (OS), cancer specific survival (CSS) and cancer-free survival (CFS). Comparison between PN and RN was realized after an adjustment by propensity score considering predefined confounding factors: age, sex, tumor size, pT stage of the TNM classification, histological type, ISUP grade, ASA score. RESULTS A total of 267 patients were included. OS at 3 and 5 years was 93.6% and 78.7% after PN and 88.0% and 76.2% after RN, respectively. CSS at 3 and 5 years was 95.4% and 80.2% after PN and 91.0% and 85.0% after RN. No significant difference between groups was found after propensity score adjustment for OS (HR 0.87, 95% CI: 0.37-2.05, P=0.75), CSS (HR 0.52, 95% CI: 0.18-1.54, P=0.24) and CFS (HR 1.02, 95% CI: 0.50-2.09, P=0.96). CONCLUSION PN seems equivalent to RN for OS, CSS and CFS in cT2a stage kidney tumors. The risk of recurrence is probably more related to prognostic factors than the surgical technique. The decision to perform a PN should depend on technical feasibility rather than tumor size, both to imperative and elective situation. LEVEL OF EVIDENCE 4.
Case reports in urology | 2016
Quang-Bao Phan; Nicolas Koutlidis; Céline Duperron; Eric Mourey; Frédéric Michel; Luc Cormier
Introduction. We report a case of spontaneous rupture of a single testicular prosthesis in a patient who had undergone bilateral orchiectomy and silicone gel-filled prosthesis insertion. The consequences of this rare event are discussed. There is no management algorithm. Case Presentation. A 55-year-old man presented to our outpatient department with altered consistency in his right testicular prosthesis and a painful right hemiscrotum with no systemic symptoms thirty-three years after the implantation of the prosthesis. We removed this implant without replacement, in accordance with the patients wishes. Conclusion. The long time between the implantation and the spontaneous rupture is remarkable and was never before described. The removal of the prosthesis was straightforward and it would have been possible to implant a new prosthesis after taking into account the condition of the skin.
Annals of Surgical Oncology | 2014
Géraldine Pignot; Laurent Salomon; Yann Neuzillet; Alexandra Masson-Lecomte; C. Lebacle; Jean-Jacques Patard; Pierre Lunardi; P. Rischmann; G. Pasticier; Jean-Christophe Bernhard; Jérémy Cohen; Marc-Olivier Timsit; Virginie Verkarre; Benoit Peyronnet; G. Verhoest; Constance le Goux; Marc Zerbib; François Brecheteau; Pierre Bigot; Stéphane Larré; Thibault Murez; Rodolphe Thuret; Emeric Lacarriere; Cécile Champy; Morgan Rouprêt; Eva Comperat; Julien Berger; Aurélien Descazeaud; H. Toledano; Cyrille Bastide
World Journal of Urology | 2016
Pierre Bigot; Jean Christophe Bernhard; Inderbir S. Gill; Nam Son Vuong; G. Verhoest; Vincent Flamand; B. Reix; Evren Süer; İlker Gökçe; Jean Baptiste Beauval; François Xavier Nouhaud; Masatoshi Eto; Eduard Baco; Toru Matsugasumi; Yvonne Chowaniec; J. Rigaud; C. Lenormand; C. Pfister; Jean François Hetet; G. Ploussard; Morgan Rouprêt; Priscilla Léon; Adnan El Bakri; S. Larré; Xavier Tillou; Arnaud Doerfler; Aurélien Descazeaud; Nicolas Koutlidis; A. Schneider; Philippe Sebe
Progres En Urologie | 2010
Isabelle Kermarrec; Philippe Mangin; Nicolas Koutlidis; Eric Mourey; Luc Cormier